Sterile drug product services: contract development, manufacturing and testing

Ten23 Health positions itself as a strategic partner for the pharmaceutical and biotech industries, focusing on the development of sterile injectable treatments. The company specializes in a comprehensive range of services, including formulation development, analytical testing, and process design, all aimed at creating safe, effective, and user-friendly medicines. Their expertise spans various therapeutic modalities, such as monoclonal antibodies, peptides, and viral vectors, ensuring that they can support clients through the entire drug development process—from early-stage formulation to commercial production. Ten23 Health emphasizes the importance of quality and regulatory compliance, operating within Biosafety Level BSL1 and BSL2 labs to maintain high standards in drug product development.

In addition to their core services, Ten23 Health is committed to sustainability and social responsibility, having achieved B Corporation certification. They integrate innovative technologies, such as RFID for tracking prefillable syringes, and collaborate with partners to enhance drug delivery systems. Their approach includes a focus on drug/device integration, ensuring that the delivery mechanisms are optimized for usability and effectiveness. By providing tailored solutions and expert guidance, Ten23 Health aims to address the unique challenges faced by their clients in the pharmaceutical landscape, ultimately contributing to the advancement of tomorrow's medicines.

Switzerland

ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. 

Our sites in Visp and Basel 🇨🇭 support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. 

More about us: www.ten23.health

Ten23 Health

Company Details